Hepatitis C virus kinetics in chimeric mice during antiviral therapy.
Dahari
Harel
H
Perelson
Alan S
AS
D000818:Animals; D000998:Antiviral Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002678:Chimera; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016174:Hepacivirus / Q000187:drug effects* / Q000502:physiology; D006526:Hepatitis C / Q000188:drug therapy*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000493:pharmacokinetics* / Q000627:therapeutic use; D051379:Mice; D011092:Polyethylene Glycols / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D016572:Cyclosporine; C100416:peginterferon alfa-2a; C499715:alisporivir